KraneShares MSCI All China Health Care Index ETF (KURE)

NYSEARCA: KURE · Real-Time Price · USD

15.13

-0.03 (-0.23%)

At close: Jun 26, 2026, 4:00 PM EDT

15.13

0.00 (0.00%)

After-hours: Jun 26, 2026, 8:00 PM EDT

-0.23% (1D)

Assets	$68.95M
Expense Ratio	0.65%
PE Ratio	22.65
Shares Out	4.55M
Dividend (ttm)	$0.71
Dividend Yield	4.73%
Ex-Dividend Date	Dec 22, 2025
Payout Ratio	106.77%
1-Year Return	-11.81%

Volume	17,625
Open	14.98
Previous Close	15.16
Day's Range	14.98 - 15.22
52-Week Low	14.38
52-Week High	21.88
Beta	0.17
Holdings	49
Inception Date	Feb 1, 2018

About KURE

Fund Home Page

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is issued by KraneShares.

Asset Class Equity

Category Greater China Region

Region Asia-Pacific

Stock Exchange NYSEARCA

Ticker Symbol KURE

ETF Provider KraneShares

Index Tracked MSCI China All Shares Health Care 10/40 Index

Top 10 Holdings

55.48% of assets

Name	Symbol	Weight
BeOne Medicines AG	6160	9.05%
Innovent Biologics, Inc.	1801	8.57%
WuXi Biologics (Cayman) Inc.	2269	7.78%
WuXi AppTec Co., Ltd.	603259	6.43%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	600276	4.63%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	300760	4.34%
WuXi AppTec Co., Ltd.	WUXIF	3.80%
CSPC Pharmaceutical Group Limited	1093	3.76%
Akeso, Inc.	9926	3.71%
Sino Biopharmaceutical Limited	1177	3.40%

View More Holdings

Dividends

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$0.71469	Dec 23, 2025
Dec 17, 2024	$0.18361	Dec 18, 2024
Dec 18, 2023	$0.11284	Dec 20, 2023
Dec 28, 2022	$0.0104	Dec 30, 2022
Dec 29, 2021	$4.05354	Dec 31, 2021
Dec 29, 2020	$0.00011	Dec 31, 2020